This Article Figures Only Full Text Full Text (PDF) Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pitman, A G Articles by MacManus, M P Search for Related Content PubMed PubMed Citation Articles by Pitman, A G Articles by MacManus, M P

Performance of sodium iodide based ¹⁸F-fluorodeoxyglucose positron emission tomography in the characterization of indeterminate pulmonary nodules or masses

Departments of ¹Diagnostic Imaging and ²Radiation Oncology, Peter MacCallum Cancer Institute, St Andrews Place, East Melbourne, Victoria 3002, Australia

Correspondence: Dr Alex G Pitman, Peter MacCallum Cancer Institute, Locked bag 1, A'Beckett Street, Melbourne, Victoria 3000, Australia

The purpose of this study was to document the accuracy of ¹⁸F-fluorodeoxyglucose (¹⁸F-FDG) positron emission tomography (PET) with sodium iodide detectors in characterizing indeterminate lung nodules or masses and in identifying additional extralesional findings. 50 consecutive patients without a confident diagnosis of malignancy on CT underwent ¹⁸FDG PET with and without attenuation correction. The diagnosis of malignancy was made using visual diagnostic criteria, and tumour-to-blood pool ratios were calculated. The final diagnosis was established by surgery, biopsy or long-term follow-up. Any additional findings made at PET were recorded and similarly verified. Using blinded visual diagnostic criteria for the differentiation of malignant from benign nodules, sodium iodide PET achieved a sensitivity of 91% (30 of 33 cases), a specificity of 88% (15 of 17 cases), a positive predictive value for malignancy of 94% (30 of 32 cases) and a negative predictive value of 83% (15 of 18 cases). False positives occurred with active tuberculosis and sarcoidosis. False negatives were a 3 cm bronchoalveolar carcinoma, a 1.3 cm sarcoma metastasis and a 1 cm carcinoma. Use of tumour-to-blood pool ratios did not improve performance. PET suggested the presence of nodal or distant metastases in 13 of 33 patients with a malignant pulmonary lesion. These PET findings were confirmed in 11 patients. These results indicate that sodium iodide PET is an accurate tool for the characterization of indeterminate pulmonary masses or nodules and simultaneously provides non-invasive staging information that can alter patient management in up to one-third of such patients. Performance of sodium iodide PET is comparable with reported results for PET scanners using other detector materials.

This article has been cited by other articles:

				J. Burrill, C. J. Williams, G. Bain, G. Conder, A. L. Hine, and R. R. Misra Tuberculosis: A Radiologic Review RadioGraphics, September 1, 2007; 27(5): 1255 - 1273. [Abstract] [Full Text] [PDF]

				N Aide, M Benayoun, K Kerrou, A Khalil, J Cadranel, and J N Talbot Impact of [18F]-fluorodeoxyglucose ([18F]-FDG) imaging in sarcoidosis: unsuspected neurosarcoidosis discovered by [18F]-FDG PET and early metabolic response to corticosteroid therapy Br. J. Radiol., March 1, 2007; 80(951): e67 - e71. [Abstract] [Full Text] [PDF]

				Y. Tomimaru, M. Higashiyama, J. Okami, K. Oda, K. Takami, K. Kodama, and Y. Tsukamoto Surgical Results of Lung Cancer with Sarcoid Reaction in Regional Lymph Nodes Jpn. J. Clin. Oncol., February 1, 2007; 37(2): 90 - 95. [Abstract] [Full Text] [PDF]

				A. F. Shorr, D. L. Helman, C. J. Lettieri, J. L. Montilla, and R. S. Bridwell Depreotide Scanning in Sarcoidosis: A Pilot Study Chest, October 1, 2004; 126(4): 1337 - 1343. [Abstract] [Full Text] [PDF]